Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.

{
  "signal_id": "32078b3a-28bf-70d8-95f5-43972f4579cf",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-10-30T12:40:00+00:00",
  "company": {
    "name": "Viatris",
    "domain": "viatris.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/viatris-announces-commencement-of-tender-offer-to-acquire-pacira-biosciences-inc-302924916.html",
    "title": "Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.",
    "excerpt": "PITTSBURGH , Oct. 30, 2026 /PRNewswire/ -- Viatris Inc. (\"Viatris\") (Nasdaq: VTRS ), a global healthcare company, today announced that Peach Purchaser Sub Inc. (\"Purchaser\"), a wholly owned subsidiary of Viatris, has commenced a tender offer to purchase all of the issued and outstanding shares of common stock, par value $0.001 per share (the \"Shares\"), of Pacira BioSciences, Inc. (\"Pacira\") (Nasdaq: PCRX ), for $36.50 per Share, in cash, net of applicable withholding taxes and without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated Oct. 30, 2026 (as it may be amended or supplemented from time to time, the \"Offer to Purchase\"), and the accompanying Letter of Transmittal (the \"Letter of Transmittal\" and, together with the Offer to Purchase and other related materials, as they may be amended or supplemented from time to time, the \"Offer\"). The Offer is being made pursuant to the Agreement and Plan of Merger, dated Oct. 8, 2026, by and among Viatris, Purchaser and Pacira (as it may be amended or supplemented from time to time, the \"Merger Agreement\"). The Merger Agreement provides, among other things, that as soon as practicable following the consummation of the Offer, on the terms and subject to the conditions set forth in the Merger Agreement and in accordance with the General Corporation Law of the State of Delaware, as amended...",
    "summary": "Viatris commenced a tender offer through its subsidiary Peach Purchaser Sub Inc. to acquire Pacira BioSciences for $36.50 per share in cash.",
    "location": "Pittsburgh, Pennsylvania, United States",
    "planning": true,
    "image_url": "https://mmx.prnewswire.com/media/MS627787/Viatris-OUS-Logo.jpg?id=OA3048339&p=facebook",
    "confidence": 0.95,
    "published_at": "2026-10-30T12:40:00Z",
    "location_data": [
      {
        "city": "Pittsburgh",
        "state": "Pennsylvania",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-10-30",
    "article_sentence": "Viatris Inc. (\"Viatris\") (Nasdaq: VTRS ), a global healthcare company, today announced that Peach Purchaser Sub Inc. (\"Purchaser\"), a wholly owned subsidiary of Viatris, has commenced a tender offer to purchase all of the issued and outstanding shares of common stock, par value $0.001 per share (the \"Shares\"), of Pacira BioSciences, Inc. (\"Pacira\") (Nasdaq: PCRX ), for $36.50 per Share, in cash, net of applicable withholding taxes and without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated Oct. 30, 2026 (as it may be amended or supplemented from time to time, the \"Offer to Purchase\"), and the accompanying Letter of Transmittal (the \"Letter of Transmittal\" and, together with the Offer to Purchase and other related materials, as they may be amended or supplemented from time to time, the \"Offer\").",
    "related_company_name": "Pacira BioSciences, Inc.",
    "related_company_domain": "pacira.com"
  }
}

curl https://signals.autobound.ai/v1/signals/32078b3a-28bf-70d8-95f5-43972f4579cf \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"viatris.com","limit":20}'